ADDISON, Texas--(BUSINESS WIRE)--Concentra Group Holdings Parent, Inc. (“Concentra,” “we,” “us,” or “our”) (NYSE: CON) today announced results for its ...

We know that obviously we've got a long tour and an important tour of Australia. Workload management will definitely depend on what the outcome of this Test match is and how much they have bowled in ...

Changes likely in India's XI for second Test against New Zealand as Rishabh Pant, Shubman Gill declared fit. Who will bat at No.6? India assistant coach Ryan ten Doeschate all but confirmed India ...

Pant hurt his knee on the second day of the Test when he was attempting to stump Devon Conway in the 37th over of New Zealand's innings. He failed to collect the ball and copped a blow.

Listen to Story Mohammed Shami bowled at full tilt at the sidelines of Bengaluru Test Shami has proclaimed that he is injury free now The pacer has not played any cricket since World Cup 2023 Injured ...

“Unrivaled comfort.” That’s how Sony positioned its new LinkBuds Fit noise-canceling wireless earbuds when they debuted alongside the company’s two other new LinkBuds products, the ...

Shares of Kezar Life Sciences (NASDAQ:KZR) fell 11% Thursday after the company said its board of directors had unanimously rejected an unsolicited takeover offer from Concentra Biosciences and ...

Earlier on Thursday, Kezar Life Sciences rejected the previously disclosed unsolicited, non-binding proposal from Concentra Biosciences for cash consideration of $1.10 per share, plus a contingent ...

After careful consideration and with the assistance of its independent financial and legal advisors, the Board unanimously concluded that the Concentra proposal substantially undervalues the Company.

Kezar Life Sciences has become the latest biotech to decide that it could do better than a buyout offer from Concentra Biosciences. Concentra’s parent company Tang Capital Partners has a track ...